Table 2

Prevalence of mutations among controls, all patients with dilated cardiomyopathy (DCM), and patients with familial and sporadic disease

Controls (all) n (%) DCM (all) n (%) OR2-150 (95% CI) Controls (male) n (%) DCM (male) n (%) OR2-150 (95% CI)
C282Y present24 (12)30 (15)1.2 (0.7 to 2.2)19(12)21(15)1.2 (0.6 to 2.3)
H63D present53 (27)74 (36)1.7 (1.1 to 2.5)2-151 42(27)56(39)1.7 (1.0 to 2.8)2-151
CH4 (2)10 (4.8)2.6 (0.8 to 8.5)3(1.9)9(6)3.2 (0.9 to 12.4)
  • 2-150 Adjusted for age and sex.

  • 2-151 p < 0.05.

  • CH, compound heterozygotes; CI, confidence interval; OR, odds ratio.